Stacey M Frumm

The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia.

Gabriela Alexe, Giovanni Roti, Nicola Tolliday, 2012, The Journal of clinical investigation.

Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation.

Giovanni Roti, Lynn VerPlank, Nicola Tolliday, 2013, Chemistry & biology.